Cargando…

Markers of Tumor-Initiating Cells Predict Chemoresistance in Breast Cancer

PURPOSE: Evidence is lacking whether the number of breast tumor-initiating cells (BT-ICs) directly correlates with the sensitivity of breast tumors to chemotherapy. Here, we evaluated the association between proportion of BT-ICs and chemoresistance of the tumors. METHODS: Immunohistochemical stainin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Chang, Yao, Herui, Liu, Qiang, Chen, Jingqi, Shi, Junwei, Su, Fengxi, Song, Erwei
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004932/ https://www.ncbi.nlm.nih.gov/pubmed/21187973 http://dx.doi.org/10.1371/journal.pone.0015630

Ejemplares similares

Ubc9 expression predicts chemoresistance in breast cancer
por: Chen, Shi-Feng, et al.
Publicado: (2011)

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
por: Liu, Jieqiong, et al.
Publicado: (2020)

Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis
por: Tan, Weige, et al.
Publicado: (2016)

Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
por: Yang, Mei, et al.
Publicado: (2011)

A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients
por: Li, Huiping, et al.
Publicado: (2018)

CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis
por: Lin, Xiaorong, et al.
Publicado: (2015)

A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer
por: Tan, Weige, et al.
Publicado: (2016)

Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer
por: Li, Qingjian, et al.
Publicado: (2020)

Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer
por: Wu, Jiannan, et al.
Publicado: (2015)

Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study
por: Chen, Yi, et al.
Publicado: (2016)

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1
por: Zhu, Yinghua, et al.
Publicado: (2018)

Conversion of Stationary to Invasive Tumor Initiating Cells (TICs): Role of Hypoxia in Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) Trafficking
por: Li, Jian, et al.
Publicado: (2012)

HGF-Induced PKCζ Activation Increases Functional CXCR4 Expression in Human Breast Cancer Cells
por: Huang, Songyin, et al.
Publicado: (2012)

Blocking the recruitment of naive CD4(+) T cells reverses immunosuppression in breast cancer
por: Su, Shicheng, et al.
Publicado: (2017)

Breast-conserving Surgery Rates in Breast Cancer Patients With Different Molecular Subtypes: An Observational Study Based on Surveillance, Epidemiology, and End Results (SEER) Database
por: Chen, Kai, et al.
Publicado: (2016)

Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis
por: Chen, Kai, et al.
Publicado: (2015)

Nerve Fibers in Breast Cancer Tissues Indicate Aggressive Tumor Progression
por: Huang, Di, et al.
Publicado: (2014)

Long Noncoding RNA HOTAIR Is a Prognostic Marker for Esophageal Squamous Cell Carcinoma Progression and Survival
por: Lv, Xiao-Bin, et al.
Publicado: (2013)

miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program
por: Su, Shicheng, et al.
Publicado: (2015)

E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter
por: Chu, Junjun, et al.
Publicado: (2015)

Predicting initial margin status in breast cancer patients during breast-conserving surgery
por: Pan, Zihao, et al.
Publicado: (2018)

In pursuit of a flawless aphrodite: paving the way to scarless oncoplastic breast surgery
por: Zhu, Liling, et al.
Publicado: (2019)

HER-2 positive breast cancer is associated with an increased risk of positive cavity margins after initial lumpectomy
por: Jia, Haixia, et al.
Publicado: (2014)

Multiple metastases of bones and sigmoid colon after mastectomy for ductal carcinoma in situ of the breast: a case report
por: You, Qiuting, et al.
Publicado: (2019)

Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
por: Wang, Hongjiang, et al.
Publicado: (2012)

Re-excision or “wait and watch”—a prediction model in breast phyllodes tumors after surgery
por: Chao, Xue, et al.
Publicado: (2020)

MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival
por: Tang, Wei, et al.
Publicado: (2012)

Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages
por: Su, Shicheng, et al.
Publicado: (2014)

Side Population Cells as Prototype of Chemoresistant, Tumor-Initiating Cells
por: Richard, Vinitha, et al.
Publicado: (2013)

The Hedgehog inhibitor cyclopamine antagonizes chemoresistance of breast cancer cells
por: Chai, Feng, et al.
Publicado: (2013)

MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
por: Ouyang, Mao, et al.
Publicado: (2014)

Identification of a tumor immune-inflammation signature predicting prognosis and immune status in breast cancer
por: Liu, Yajing, et al.
Publicado: (2023)

Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer
por: Shao, Bin, et al.
Publicado: (2019)

Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines
por: Hsiao, Yen-Ling, et al.
Publicado: (2014)

Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics–Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer
por: Yu, Yunfang, et al.
Publicado: (2020)

Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer
por: Yu, Yunfang, et al.
Publicado: (2020)

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer
por: Liu, Jieqiong, et al.
Publicado: (2022)

The Role of Circulating Tumor Cells in Chemoresistant Metastatic Breast Cancer
por: Lisencu, Lorena Alexandra, et al.
Publicado: (2021)

Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study
por: Yu, Yunfang, et al.
Publicado: (2021)

Clinicopathological Characteristics and Treatment Strategies of Triple-Negative Breast Cancer Patients With a Survival Longer than 5 Years
por: Xie, Ning, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t7tvil4jebtjepb85vc2fnmanj